Close

IBI Lorenzini trains the young pharmacists of Camerun

19 November 2017

Contribute to the spreading of pharmaceutical culture and activities in developing countries: with this objective, Istituto Biochimico Italiano Giovanni Lorenzini has decided to celebrate its 100 years in 2018 with a competition for the awarding of 3 scholarships (of a value of 10 thousand Euro each plus the ticket to return to their own country) to young graduate students from Camerun at the Faculties of Pharmacy of the Universities of Camerino, Urbino and Roma Tor Vergata. Thanks to these scholarships, the young pharmacists will be able to return to Camerun and start a galenic pharmaceutical activity with the double objective of selling the products that they have developed and set the foundation for a first virtuous self-sustainment circuit.

The collaboration with the academic world is the result of not just the strong attention to social responsibility, but also of the desire to tangibly promote the practical formation of the students: it is for this reason that IBI Lorenzini will welcome the winners for a period of three months at their premises of Aprilia (Latina), so that they can acquire skills in pharmaceutical techniques and quality control. All this will be followed by a 9-month period at the Catholic University of Camerun, which recently instituted a Galenic Laboratory in Bamenda, thanks to funds from CEI with the 8x1000 contributions.

The winners of the scholarships will be selected by an appropriate commission consisting of an IBI representative and three university professors, one for each of the universities promoting the initiative.

“Contributing to the spreading of scientific culture and invest in young talents in such an important field as the pharmaceutical sector is part of the original mission,” explains Camilla Borghese Khevenhüller, President of IBI Lorenzini “but we do it through field training, the practical type of training, because learning within a professional framework will allow these young individuals to deeply explore the production and organisational processes, making it easier for them to acquire knowledge and skills.” 

The applications for taking part in the competition must be sent by the 31 October directly to the Personnel Office of IBI Lorenzini, at the following mail address: ufficiopersonale@ibi-lorenzini.com indicating “Bando Borse di studio” (Scholarship competition) in the object.

For the requirements for participation to the competition visit: site.

Latest news

undefined

REVER3MAB: "An ambitious project for the development of an innovative biological drug"?

IBI collaborates in the development of an innovative biological drug to revert resistance to conventional cancer treatments: project: REVER3MAB (EU, State and Region)

Read all
undefined

Seguiamo i farmaci fino a voi

Cinquanta milioni di investimento digitale e un forte impegno nella tracciabilità dei prodotti

Read all
undefined

Ibi partecipa all'iniziativa UniCredit 4 Growth

Read all

Thank you

We sent you an email. To activate the newsletter click on the link you will find in the message, thank you!

Sign up for the newsletter


Dichiarazione in merito al GDPR (Regolamento Generale Protezione dei Dati)

In caso di sottoscrizione Newsletter dovrai confermare l’iscrizione per mezzo di mail di conferma inviata all’indirizzo inserito. In tal caso il trattamento prevede:

la profilazione dell’utente in gruppi, status, preferenze secondo quanto indicato e dedotto dalle informazioni inviate tramite il form o successiva autonoma profilazione.
l’utilizzo del dato per l’invio di comunicazione a mezzo digitale (email, whatsapp) e non (cartaceo) avente scopo informativo/commerciale.
l'utilizzo della mail per la generazione di campagne marketing e informative personalizzate, digitali e non.

Cancel
CHIUDI


Private area


Log in to restricted area


Registration


Notice on the treatment of personal data

Dear visitor, in the following sections we will describe how the reserved area of the www.ibi-lorenzini.it website is managed as far as processing personal data of users. The notice is issued pursuant to art. 13 of EU Regulation 679/2016 (hereinafter also the Regulation) on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and applies to those who interact with the website of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (hereinafter I.B.I.), which can be accessed at the following address: www.ibi-lorenzini.it, the opening page of the official I.B.I. website. The notice only applies to the I.B.I. website. It does not apply to any other websites that the user may access through links.

  1. The processing of the personal data that you supply, which are also used for the creation of your user profile, and which will be included in the “Doctors’ Details” database, has the following purposes:
  • carry out medical sales related activities for drugs for human consumption. Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. and Ibigen S.r.l., part of the same company group (hereinafter also Ibigen Group), carry out such activities in compliance with the provisions of the current regulations, with particular, but not exclusive, attention to Italian Legislative Decree no. 219 of 24.04.2006 and subsequent modifications. In view of the objectives of the Ibigen Group, it is important to point out that the processing activities do not deal with any special data. The supply of the data for the medical sales activities is necessary, and failure to provide consent will make it impossible for us to fulfil the above objectives;

  • forwarding of invitations or information on congresses, conferences, seminars, communications on initiatives promoted or sponsored by the Ibigen group, regular or occasional publications, information on new products, methods and services. Such activities are carried out by e-mail, fax, SMS, normal post or telephone. The supply of the data for such purposes is optional, and failure to supply them will result in the information not being forwarded.

  1. As far as the creation of your profile on our website, we remind you that your password is strictly confidential and should not be disclosed.
  2. Your data will not be disclosed, but may be shared with individuals, companies, associations or professional studios providing support or consultancy services to the Ibigen Group, the medical sales representative network, our suppliers and any sub-suppliers - from time to time entrusted with activities connected with the above objectives -, mailing or statistical survey companies, or companies for the forwarding of scientific documentation, and individuals authorised to access the data by law and/or pursuant to secondary regulations.
  3. Such people may only acquire knowledge of your personal data for the above mentioned purposes.
  4. The Owners of the Treatment (Data Controllers) are the two companies of the Ibigen Group with legal headquarters at Via Fossignano no. 2, Aprilia (LT), Italy.
  5. Personal data are processed using manual and automated means, for the time necessary for reaching the objectives for which they were collected. Special safety measures are in place to avoid data loss, unlawful or incorrect use and unauthorised access.
  6. Lastly, we also inform you that you can at any time exercise the rights contemplated by the Regulation, and in particular request access to the data, their correction, update and block, or you can withdraw your consent, or request the limitation of the processing or the cancellation of the data. As data subject, you also have the right to issue a complaint with the relevant control Authority. Such rights may be exercised in writing to the following e-mail address: info@ibi-lorenzini.com.
  7. The Data Protection Officer may be contacted at the following e-mail address: dpo_ibi@protectiontrade.it

* Required fields

Cancel